Statement Of Changes In Equity [Abstract]

Transgene - Filing #6250839

Concept 2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of changes in equity [abstract]
Statement of changes in equity [line items]
Equity
105 760 EUR
88 711 EUR
66 147 EUR
33 971 EUR
522,000 EUR
15 203 EUR
446,000 EUR
15 612 EUR
83 432 EUR
22 328 EUR
432,000 EUR
71 156 EUR
50 426 EUR
642,000 EUR
37 841 EUR
50 628 EUR
32 804 EUR
808,000 EUR
450,000 EUR
70 813 EUR
50 102 EUR
Changes in equity [abstract]
Comprehensive income [abstract]
Profit (loss)
33 971 EUR
- EUR
- EUR
- EUR
- EUR
33 971 EUR
- EUR
22 328 EUR
22 328 EUR
- EUR
- EUR
- EUR
- EUR
- EUR
Other comprehensive income
196,000 EUR
192,000 EUR
Comprehensive income
33 971 EUR
- EUR
- EUR
- EUR
- EUR
33 775 EUR
196,000 EUR
22 520 EUR
22 328 EUR
- EUR
- EUR
- EUR
- EUR
192,000 EUR
Increase (decrease) through treasury share transactions, equity
- EUR
- EUR
44,000 EUR
- EUR
- EUR
44,000 EUR
- EUR
1,000 EUR
- EUR
- EUR
1,000 EUR
- EUR
- EUR
- EUR
Increase (decrease) through share-based payment transactions, equity
- EUR
- EUR
- EUR
- EUR
568,000 EUR
568,000 EUR
- EUR
290,000 EUR
- EUR
- EUR
- EUR
290,000 EUR
- EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.